Clinical Significance of Clostridium difficile Toxin Variants

艰难梭菌毒素变异体的临床意义

• 批准号: 7783810
• 负责人: Stuart Brian Johnson
• 金额: --
• 依托单位: EDWARD HINES JR VA HOSPITAL
• 依托单位国家: 美国
• 财政年份: 2009
• 资助国家: 美国
• 起止时间: 2009-04-01 至 2013-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7783810
• 关键词: 1 year old; ADP Ribose Transferases; Actins; Affect; Age; Animal Model; Antibiotics; Biological Assay; Canada; Cessation of life; Characteristics; Clinical; Clostridium difficile; Colitis; Cytotoxin; Data; Diagnosis; Diarrhea; Disease; Disease Outbreaks; Elderly; Epidemic; Epithelial; Europe; Frequencies; Gene Expression; Genes; Genome; Grant Review; Hamsters; Healthcare; Hospital Records; Hospitals; Human; In Vitro; Intestines; Laboratories; Lead; Length of Stay; Light; Link; Liquid substance; Modeling; Molecular; Mus; North America; Oryctolagus cuniculus; Pathogenesis; Pathogenicity; Patients; Persons; Phase; Principal Investigator; Production; Quebec; Reporting; Research; Restriction fragment length polymorphism; Risk; Risk Factors; Severity of illness; Testing; Tight Junctions; Toxin; Toxoids; Vaccination; Variant; Veterans; Veterans Hospitals; Virulence; Virulence Factors; Virulent; Work; abstracting; clinically significant; factor C; fluoroquinolone resistance; improved; in vitro testing; monolayer; mutant; patient population; polarized cell; programs; public health relevance; research study; response